Vancouver, B.C. and Boston, MA, August 27, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported financial results for the three months ended June 30, 2019. All amounts, unless otherwise specified, are expressed in Canadian dollars and are presented in accordance with International Financial Reporting Standards (IFRS). Recent Corporate Developments - In April 2019, Imagin reached a major product development milestone with completion of the i/Blue™ Imaging ...
[ more ]
